Grants per year
Fingerprint
Dive into the research topics where Rom Leidner is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 4 Active
-
Molecular Cytology in Barrett's Esophagus
Leidner, R. (PI)
American Society of Clinical Oncology
01/1/12 → …
Project: Research
-
-
A Study of Genetic Evolution from Barrett's Esophagus to Adenocarcinoma
Leidner, R. (PI)
American Society of Clinical Oncology
01/1/09 → …
Project: Research
-
A Study of Genetic Evolution from Barrett's Esophagus to Adenocarcinoma.
Leidner, R. (PI)
01/1/09 → …
Project: Research
-
Approaches to overcome the current treatment plateau in immunotherapy
Di Giacomo, A. M., Canetta, R., Connolly, J., Leidner, R., Zheng, W., Kim, Y., Ibrahim, R., Lahn, M., Smith, M., Eggermont, A., Fox, B. A. & Maio, M., Aug 26 2025, In: European Journal of Cancer. 226, 115605.Research output: Contribution to journal › Review article › peer-review
2 Scopus citations -
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial
Lopez, J., Powles, T., Braiteh, F., Siu, L. L., LoRusso, P., Friedman, C. F., Balmanoukian, A. S., Gordon, M., Yachnin, J., Rottey, S., Karydis, I., Fisher, G. A., Schmidt, M., Schuler, M., Sullivan, R. J., Burris, H. A., Galvao, V., Henick, B. S., Dirix, L. & Jaeger, D. & 60 others, , Jan 2025, In: Nature Medicine. 31, 1, p. 152-164 13 p., e150535.Research output: Contribution to journal › Article › peer-review
Open Access36 Scopus citations -
Efficacy and safety of one-time autologous tumor-infiltrating lymphocyte cell therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
Ferris, R. L., Leidner, R. S., Chung, C. H., Jimeno, A., Lee, S. M., Sukari, A., Nieva, J. J., Grilley-Olson, J. E., Redman, R., Wong, S. J., Villaflor, V. M., Misleh, J., Finckenstein, F. G., Chou, J., Gastman, B., Fiaz, R., Catlett, M., Yi, M. & Cohen, E. E. W., Aug 24 2025, In: Journal for ImmunoTherapy of Cancer. 13, 8, e011633.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
An open-label, phase 1, multicenter study to evaluate the safety and preliminary anti-tumor activity of NT-112 in human leukocyte antigen-C*08:02–positive adult patients with unresectable, advanced, and/or metastatic solid tumors that are positive for the KRAS G12D mutation
Morelli, M., Leidner, R. & comments, S. F. L. O. A. I., Jun 1 2024Research output: Other contribution
-
A phase1 study of autologous engineered CD4+ and CD8+ T cells, HLA-A*11:01-restricted, KRAS G12V-specific, transgenic TCR; CD8α/β coreceptor and a FAS41BB switch receptor in patients with solid tumors
Mitchell, S., Leidner, R. & comments, S. F. L. O. A. I., Nov 1 2024Research output: Other contribution